Ingalls & Snyder LLC’s Medtronic MDT Stock Holding History

Ingalls & Snyder LLC’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.75M	Hold	20,171	–	–	0.06%	167
2025 Q4	$1.94M	Buy	20,171 +790	+4%	+$76.7K	0.07%	163
2025 Q3	$1.85M	Sell	19,381 -730	-4%	-$67.1K	0.06%	168
2025 Q2	$1.75M	Sell	20,111 -1,500	-7%	-$127K	0.06%	167
2025 Q1	$1.94M	Buy	21,611 +113	+0.5%	+$10.1K	0.06%	154
2024 Q4	$1.72M	Sell	21,498 -7,700	-26%	-$667K	0.07%	157
2024 Q3	$2.63M	Buy	29,198 +6,989	+31%	+$588K	0.1%	128
2024 Q2	$1.75M	Sell	22,209 -1,253	-5%	-$103K	0.08%	156
2024 Q1	$2.04M	Buy	23,462 +31	+0.1%	+$2.65K	0.09%	141
2023 Q4	$1.93M	Sell	23,431 -390	-2%	-$29.7K	0.09%	142
2023 Q3	$1.87M	Sell	23,821 -425	-2%	-$35.6K	0.09%	148
2023 Q2	$2.14M	Buy	24,246 +650	+3%	+$56K	0.1%	133
2023 Q1	$1.9M	Hold	23,596	–	–	0.1%	142
2022 Q4	$1.83M	Sell	23,596 -5,997	-20%	-$486K	0.1%	140
2022 Q3	$2.39M	Sell	29,593 -1,245	-4%	-$112K	0.13%	115
2022 Q2	$2.77M	Sell	30,838 -1,053	-3%	-$107K	0.14%	111
2022 Q1	$3.54M	Sell	31,891 -825	-3%	-$87.2K	0.16%	108
2021 Q4	$3.38M	Sell	32,716 -1,150	-3%	-$133K	0.15%	123
2021 Q3	$4.25M	Sell	33,866 -1,352	-4%	-$175K	0.19%	100
2021 Q2	$4.37M	Buy	35,218 +216	+0.6%	+$27.1K	0.19%	94
2021 Q1	$4.13M	Buy	35,002 +198	+0.6%	+$23.2K	0.19%	96
2020 Q4	$4.08M	Sell	34,804 -109	-0.3%	-$12K	0.2%	93
2020 Q3	$3.63M	Buy	34,913 +344	+1%	+$34.5K	0.25%	82
2020 Q2	$3.17M	Sell	34,569 -3,082	-8%	-$296K	0.18%	100
2020 Q1	$3.4M	Sell	37,651 -3,864	-9%	-$411K	0.23%	87
2019 Q4	$4.71M	Sell	41,515 -282	-0.7%	-$30.9K	0.26%	85
2019 Q3	$4.54M	Sell	41,797 -1,520	-4%	-$159K	0.22%	96
2019 Q2	$4.22M	Sell	43,317 -8,441	-16%	-$771K	0.2%	97
2019 Q1	$4.71M	Sell	51,758 -6,250	-11%	-$559K	0.22%	96
2018 Q4	$5.28M	Buy	58,008 +2,155	+4%	+$201K	0.28%	85
2018 Q3	$5.49M	Buy	55,853 +52,070	+1,376%	+$4.81M	0.23%	93
2018 Q2	$324K	Sell	3,783 -530	-12%	-$44.3K	0.02%	325
2018 Q1	$346K	Sell	4,313 -57	-1%	-$4.7K	0.02%	303
2017 Q4	$353K	Sell	4,370 -301	-6%	-$24.1K	0.02%	305
2017 Q3	$363K	Buy	4,671 +18	+0.4%	+$1.49K	0.02%	276
2017 Q2	$413K	Sell	4,653 -975	-17%	-$82.2K	0.02%	254
2017 Q1	$453K	Sell	5,628 -71	-1%	-$5.55K	0.02%	265
2016 Q4	$406K	Buy	5,699 +383	+7%	+$30.1K	0.02%	272
2016 Q3	$459K	Buy	5,316 +203	+4%	+$17.7K	0.03%	260
2016 Q2	$444K	Hold	5,113	–	–	0.03%	270
2016 Q1	$383K	Hold	5,113	–	–	0.02%	251
2015 Q4	$393K	Sell	5,113 -250	-5%	-$18.8K	0.03%	253
2015 Q3	$358K	Hold	5,363	–	–	0.02%	258
2015 Q2	$397K	Buy	5,363 +225	+4%	+$17.2K	0.02%	256
2015 Q1	$400K	Buy	5,138 +563	+12%	+$42.7K	0.02%	256
2014 Q4	$330K	Buy	4,575 +50	+1%	+$3.47K	0.02%	279
2014 Q3	$280K	Sell	4,525 -200	-4%	-$12.7K	0.02%	304
2014 Q2	$301K	Hold	4,725	–	–	0.01%	299
2014 Q1	$290K	Sell	4,725 -946	-17%	-$55.1K	0.02%	292
2013 Q4	$325K	Hold	5,671	–	–	0.02%	272
2013 Q3	$301K	Hold	5,671	–	–	0.02%	274
2013 Q2	$291K	Buy	+5,671	New	+$280K	0.02%	280

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ingalls & Snyder LLC's MDT Position: Q1 2026 in Review

Ingalls & Snyder LLC held its Medtronic (MDT) position steady in Q1 2026 at 20,171 shares worth $1.75M. The position accounts for 0.06% of the portfolio, ranked #167.

Ingalls & Snyder LLC first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.49M in Q3 2018. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Ingalls & Snyder LLC held 20,171 shares of Medtronic worth $1.75M as of Q1 2026.
Ingalls & Snyder LLC left its Medtronic share count unchanged in Q1 2026.
Medtronic made up 0.06% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #167 holding.
Ingalls & Snyder LLC first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
Ingalls & Snyder LLC's Medtronic position peaked at $5.49M in Q3 2018.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.